Literature DB >> 7812948

Localization of tumor suppressor loci on chromosome 9 in primary human renal cell carcinomas.

P Cairns1, K Tokino, Y Eby, D Sidransky.   

Abstract

To investigate the potential loss of tumor suppressor gene loci on chromosome 9 in human renal cell tumorigenesis we analyzed 42 paired normal and tumor DNAs with 18 polymorphic microsatellite markers spanning this chromosome. Fourteen of 42 (33%) tumors showed partial or complete deletion of chromosome 9. Deletion mapping provided evidence for the presence of a suppressor locus on both the short and long arm of chromosome 9. Homozygous deletion at 9p21-22 in one renal tumor and a selective deletion of distal 9q in another tumor localized the critical regions. The CDKN2/p16 gene was further investigated as a candidate suppressor locus on 9p21-22 by multiplex PCR, Southern analysis, and exon sequencing. We found no additional cases of homozygous deletion nor any rearrangements or point mutations of CDKN2/p16. This is the first report of 9p loss of heterozygosity, homozygous deletion of 9p21-22 and selective deletion of 9q in primary renal cell carcinomas. Understanding the molecular genetic basis of renal cell progression will require the isolation and characterization of additional tumor suppressor genes on chromosome 9.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7812948

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  21 in total

1.  CDKNA2A mutation analysis, protein expression, and deletion mapping of chromosome 9p in conventional clear-cell renal carcinomas: evidence for a second tumor suppressor gene proximal to CDKN2A.

Authors:  P Schraml; K Struckmann; R Bednar; W Fu; T Gasser; K Wilber; J Kononen; G Sauter; M J Mihatsch; H Moch
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

Review 2.  Ovarian clear cell adenocarcinoma: a continuing enigma.

Authors:  David S P Tan; Stan Kaye
Journal:  J Clin Pathol       Date:  2006-10-03       Impact factor: 3.411

3.  Evaluation of the clonal relationship between primary and metastatic renal cell carcinoma by comparative genomic hybridization.

Authors:  H Bissig; J Richter; R Desper; V Meier; P Schraml; A A Schäffer; G Sauter; M J Mihatsch; H Moch
Journal:  Am J Pathol       Date:  1999-07       Impact factor: 4.307

Review 4.  Renal cell carcinoma.

Authors:  Paul Cairns
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

Review 5.  Signaling pathways in renal cell carcinoma.

Authors:  Gowrishankar Banumathy; Paul Cairns
Journal:  Cancer Biol Ther       Date:  2010-10-01       Impact factor: 4.742

6.  Tuberous sclerosis-associated renal cell carcinoma. Clinical, pathological, and genetic features.

Authors:  J Bjornsson; M P Short; D J Kwiatkowski; E P Henske
Journal:  Am J Pathol       Date:  1996-10       Impact factor: 4.307

7.  Recessive oncogenes: current status.

Authors:  Xiang Gao; Kenneth V Honn
Journal:  Pathol Oncol Res       Date:  1995       Impact factor: 3.201

8.  Molecular differential diagnosis of renal cell carcinomas by microsatellite analysis.

Authors:  P Bugert; G Kovacs
Journal:  Am J Pathol       Date:  1996-12       Impact factor: 4.307

Review 9.  Molecular differential diagnosis of renal carcinoma: from microscopes to microsatellites.

Authors:  G Steiner; D Sidransky
Journal:  Am J Pathol       Date:  1996-12       Impact factor: 4.307

10.  Loss of heterozygosity and methylation of p16 in renal cell carcinoma.

Authors:  M T Sanz-Casla; M L Maestro; V del Barco; I Zanna; J Moreno; M Vidaurreta; I Almansa; C Fernández; J Blanco; C Maestro; L Resel
Journal:  Urol Res       Date:  2003-03-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.